Why tumour markers are not recommended as screening tests

ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC

Applying the syndemic framework to cancer research for effective cancer control in LMICs

Addition of Salmonella-IL2 to FOLFIRINOX for metastatic stage 4 pancreatic cancer nearly doubles median survival

IO-108 shows promising results in the treatment of advanced relapsed or refractory solid tumours

Higher BMI may be linked with worse survival among SBS88 positive CRC patients

Test identifies tumour-infiltrating cell densities as prognostic biomarkers across a pan-cancer cohort

Key practices for handling difficult conversations in cancer care

Indications for the appropriate use of a PET-CT scan for common cancers

Choosing Wisely in neoadjuvant treatment for different cancers in the Philippines

Current indications and challenges with IORT in the Philippines

A multidisciplinary team approach to cancer care in the Philippines